1. All‐oral 12‐week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY‐3 phase III study. Issue 4 (10th March 2015) Authors: Nelson, David R.; Cooper, James N.; Lalezari, Jacob P.; Lawitz, Eric; Pockros, Paul J.; Gitlin, Norman; Freilich, Bradley F.; Younes, Ziad H.; Harlan, William; Ghalib, Reem; Oguchi, Godson; Thuluvath, Paul J.; Ortiz‐Lasanta, Grisell; Rabinovitz, Mordechai; Bernstein, David; Bennett, Michael; Hawk... Journal: Hepatology Issue: Volume 61:Issue 4(2015:Apr.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗